• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组织型纤溶酶原激活剂(t-PA)的稳定性

The stability of tissue plasminogen activator (t-PA).

作者信息

Gaffney P J, Templeman J, Curtis A D, Campbell P J

出版信息

Thromb Haemost. 1983 Oct 31;50(3):650-1.

PMID:6685926
Abstract

Since tissue-type plasminogen activator (t-PA) derived from tissue culture and recombinant DNA procedures has been proposed for use in thrombolytic therapy in man, it is essential that the t-PA molecule should display reasonable stability in a lyophilised state to facilitate its usefulness. In this study, four laboratories compared the potencies of three preparations of t-PA following storage at 4 degrees, 20 degrees, 37 degrees and 45 degrees C, using each t-PA stored at -20 degrees C as a reference (100% activity) in each case. A pig heart extract of t-PA was the most stable, losing no activity when stored for 30 days at 37 degrees C, while two melanoma cell tissue culture extracts varied in their storage behaviour. One was quite stable at 37 degrees C (losing about 3% of its activity) while the other lost about 16%. Thus both the pig heart t-PA and one t-PA from melanoma cell culture proved suitable for the further development of reference standards for t-PA activity.

摘要

由于源自组织培养和重组DNA程序的组织型纤溶酶原激活剂(t-PA)已被提议用于人类的溶栓治疗,因此t-PA分子在冻干状态下应具有合理的稳定性以方便其使用,这一点至关重要。在本研究中,四个实验室比较了三种t-PA制剂在4℃、20℃、37℃和45℃储存后的效价,每种情况下均将储存在-20℃的t-PA用作参考(100%活性)。猪心t-PA提取物最稳定,在37℃储存30天后无活性损失,而两种黑色素瘤细胞组织培养提取物的储存行为有所不同。一种在37℃相当稳定(活性损失约3%),而另一种损失约16%。因此,猪心t-PA和一种来自黑色素瘤细胞培养的t-PA都被证明适用于进一步开发t-PA活性参考标准。

相似文献

1
The stability of tissue plasminogen activator (t-PA).组织型纤溶酶原激活剂(t-PA)的稳定性
Thromb Haemost. 1983 Oct 31;50(3):650-1.
2
A collaborative study of a proposed international standard for tissue plasminogen activator (t-PA).一项关于组织型纤溶酶原激活剂(t-PA)拟议国际标准的合作研究。
Thromb Haemost. 1985 Feb 18;53(1):134-6.
3
A collaborative study to establish a standard for high molecular weight urinary-type plasminogen activator (HMW/u-PA).一项建立高分子量尿型纤溶酶原激活剂(HMW/u-PA)标准的合作研究。
Thromb Haemost. 1990 Nov 30;64(3):398-401.
4
A collaborative study to establish the 2nd international standard for tissue plasminogen activator (t-PA).一项建立组织型纤溶酶原激活剂(t-PA)第二个国际标准的合作研究。
Thromb Haemost. 1987 Dec 18;58(4):1085-7.
5
[Development of new thrombolytic substances].[新型溶栓物质的研发]
Herz. 1994 Dec;19(6):314-25.
6
Clinical experience with tissue plasminogen activator stored at -20 degrees C.
Ophthalmic Surg. 1992 Nov;23(11):780-1.
7
Expression of plasminogen activators and plasminogen activator inhibitors in cutaneous melanomas of transgenic melanoma-susceptible mice.转基因黑色素瘤易感小鼠皮肤黑色素瘤中纤溶酶原激活剂和纤溶酶原激活剂抑制剂的表达
Cancer Res. 1995 Oct 15;55(20):4681-7.
8
The international standard for plasminogen activator inhibitor-1 (PAI-1) activity.纤溶酶原激活物抑制剂-1(PAI-1)活性的国际标准。
Thromb Haemost. 1996 Jul;76(1):80-3.
9
In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters.体外凝块溶解作为血栓对纤维蛋白溶解抵抗的潜在指标——在健康受试者中的研究及其与血液纤溶参数的相关性
Thromb Haemost. 1997 Apr;77(4):725-9.
10
[Anaphylactoid reaction during administration of tissue plasminogen activator (t-PA)].[组织型纤溶酶原激活剂(t-PA)给药期间的类过敏反应]
G Ital Cardiol. 1997 Mar;27(3):278-80.